功能性便秘对儿童的危害及其诊治进展

doi:10.12372/jcp.2026.25e1521

摘要/Abstract

摘要：

功能性便秘是儿童期最常见的功能性胃肠病之一，可表现为排便频次减少、粪质干硬、腹胀及腹痛等消化道症状，若疾病迁延不愈，还可继发生长发育迟缓、尿潴留、焦虑等问题，显著降低患儿生活质量。然而，目前针对儿童功能性便秘远期危害的循证研究匮乏，部分临床医师对其认知不足，加之患儿及家长依从性差，常导致诊疗延误。鉴于此，本文系统梳理功能性便秘对儿童的潜在危害及诊治进展，以期提高临床工作者与患儿家庭对该病的重视程度，优化管理策略并改善预后。

关键词: 功能性便秘, 危害, 治疗, 儿童

Abstract:

Functional constipation is one of the most common digestive system diseases in children, which can cause symptoms such as reduced defecation, hard and dry stools, abdominal distension, and abdominal pain. Long-term constipation can also lead to related problems such as delayed growth and development, urinary retention, and anxiety in children, seriously affecting their quality of life. However, at present, there is a lack of evidence-based research on the long-term hazards of functional constipation in children. Some clinicians have insufficient understanding of it, and the poor compliance of children and their parents often leads to delays in diagnosis and treatment. In view of this, this article systematically reviews the potential hazards of functional constipation to children and the progress in its diagnosis and treatment, with the aim of enhancing the attention of clinical workers and families of affected children to this disease, optimizing management strategies and improving prognosis.

Key words: functional constipation, hazard, treatment, child

中图分类号:

范娜, 王宝西, 林燕, 王春晖, 张安定, 江逊. 功能性便秘对儿童的危害及其诊治进展[J]. 临床儿科杂志, 2026, 44(4): 355-361.

FAN Na, WANG Baoxi, LIN Yan, WANG Chunhui, ZHANG Anding, JIANG Xun. The hazards of functional constipation in children and the progress in its diagnosis and treatment[J]. Journal of Clinical Pediatrics, 2026, 44(4): 355-361.

参考文献 51

[1]	Tran DL, Sintusek P. Functional constipation in children: What physicians should know[J]. World J Gastroenterol, 2023, 29(8): 1261-1288.
[2]	Rajindrajith S, Devanarayana NM, Benninga MA. Childhood constipation: current status, challenges, and future perspectives[J]. World J Clin Pediatr, 2022, 11(5): 385-404.
[3]	Chowdhury K, Sinha S, Kumar S, et al. Constipation: a pristine universal pediatric health delinquent[J]. Cureus, 2024, 16(1): e52551.
[4]	Hasosah M. Chronic refractory constipation in children: think beyond stools[J]. Glob Pediatr Health, 2021, 8: 2333794X211048739.
[5]	Benninga MA, Faure C, Hyman PE, et al. Childhood functional gastrointestinal disorders: neonate/toddler[J]. Gastroenterology, 2016, 150(6): 1443-1455.
[6]	李在玲. 0-6月龄婴儿功能性胃肠病的临床特征与诊疗进展[J]. 临床儿科杂志, 2025, 43(8): 563-568.
	Li ZL. Clinical characteristics, diagnosis and treatment progress of functional gastrointestinal disorders in infants aged 0-6 months [J]. Linchuang Erke Zazhi, 2025, 43(8): 563-568.
[7]	Hyams JS, Di Lorenzo C, Saps M, et al. Functional disorders: children and adolescents[J]. Gastroenterology, 2016, 150(6): 1456-1468.
[8]	Fedele F, Fioretti MT, Scarpato E, et al. The ten "hard" questions in pediatric functional constipation[J]. Ital J Pediatr, 2024, 50(1): 64.
[9]	Shen ZY, Zhang J, Bai YZ, et al. Diagnosis and management of fecal incontinence in children and adolescents[J]. Front Pediatr, 2022, 10: 1034240.
[10]	Dimopoulou K, Dimopoulou A, Dimopoulou D, et al. Benign anorectal disease in children: What do we know?[J]. Arch Pediatr, 2022, 29(3): 171-176.
[11]	Kodia K, Huerta CT, Perez EA. Rectal prolapse in the pediatric population-a narrative review of medical and surgical management[J]. Transl Gastroenterol Hepatol, 2024, 9: 47.
[12]	Takeda T, Hojo M, Asaoka D, et al. Targeting gut microbiota in the management of functional constipation: a narrative review[J]. Intern Med, 2025. doi: 10.2169/internalmedicine.6457-25.
[13]	Jomehzadeh N, Javaherizadeh H, Amin M, et al. Quantification of intestinal lactobacillus species in children with functional constipation by quantitative real-time PCR[J]. Clin Exp Gastroenterol, 2020, 13: 141-150.
[14]	Szczuko M, Duliban G, Drozd A, et al. The association of short-chain fatty acids with the occurrence of gastrointestinal symptoms in infants[J]. Int J Mol Sci, 2024, 25(23): 12487.
[15]	Pan R, Wang L, Xu X, et al. Crosstalk between the gut microbiome and colonic motility in chronic constipation: potential mechanisms and microbiota modulation[J]. Nutrients, 2022, 14(18): 3704.
[16]	Chiba T, Kikuchi S, Omori S, et al. Chronic constipation and acute urinary retention[J]. Eur J Gastroenterol Hepatol, 2022, 34: e1-e2.
[17]	Schmidt AM, Hirsch K, Schroth M, et al. Acute urinary retention in children[J]. J Pediatr Urol, 2020, 16(6): 842. e1-842.e6.
[18]	Iguchi N, Carrasco A Jr, Xie AX, et al. Functional constipation induces bladder overactivity associated with upregulations of Htr2 and Trpv2 pathways[J]. Sci Rep, 2021, 11(1): 1149.
[19]	Axelgaard S, Kristensen R, Kamperis K, et al. Functional constipation as a risk factor for pyelonephritis and recurrent urinary tract infection in children[J]. Acta Paediatr, 2023, 112(3): 543-549.
[20]	Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood[J]. Pediatrics, 1997, 100: 228-232.
[21]	Lazarus G, Junaidi MC, Oswari H. Relationship of functional constipation and growth status: a systematic review and meta-analysis[J]. J Pediatr Gastroenterol Nutr, 2022, 75(6): 702-708.
[22]	Oswari H, Junaidi MC, Oswari JS, et al. Association between functional constipation and growth status in children based on anthropometric indices[J]. Pediatr Gastroenterol Hepatol Nutr, 2025, 28(6): 352-358.
[23]	Bai X, Guo X, Zhou Z, et al. Functional gastrointestinal disorders are highly prevalent in children with short stature and linked to reduced growth velocity[J]. J Pediatr Gastroenterol Nutr, 2025, 81(6): 1460-1468.
[24]	Chao HC, Chen SY, Chen CC, et al. The impact of constipation on growth in children[J]. Pediatr Res, 2008, 64(3): 308-311.
[25]	McCague Y, Hill K, Furlong E, et al. The psychosocial impact of childhood constipation on the children and family: a scoping review[J]. J Pediatr Nurs, 2025, 82: e142-e163.
[26]	Flankegård G, Mörelius E, Rytterström P. Everyday life with childhood functional constipation: a qualitative phenomenological study of parents' experiences[J]. J Pediatr Nurs, 2022, 67: e165-e171.
[27]	Erdur B, Ayar M. The treatment of functional constipation significantly increased quality of life in children aged 4-17 years [J]. Turk J Gastroenterol, 2020, 31(11): 814-818.
[28]	Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN[J]. J Pediatr Gastroenterol Nutr, 2014, 58(2): 258-274.
[29]	de Oliveira MBB, Jardim-Botelho A, de Morais MB, et al. Impact of infant milk-type and childhood eating behaviors on functional constipation in preschool children[J]. J Pediatr Gastroenterol Nutr, 2021, 73(3): e50-e56.
[30]	李在玲. 关注食物过敏相关消化系统症状的鉴别[J]. 临床儿科杂志, 2024, 42(4): 285-290.
	Li ZL. Focus on the identification of digestive symptoms associated with food allergy[J]. Linchuang Erke Zazhi, 2024, 42(4): 285-290.
[31]	Cassettari VMG, Machado NC, Lourenção PLTA, et al. Combinations of laxatives and green banana biomass on the treatment of functional constipation in children and adolescents: a randomized study[J]. J Pediatr (Rio J), 2019, 95(1): 27-33.
[32]	van der Schoot A, Helander C, Whelan K, et al. Probiotics and synbiotics in chronic constipation in adults: a systematic review and meta-analysis of randomized controlled trials[J]. Clin Nutr, 2022, 41(12): 2759-2777.
[33]	Liu L, Wang A, Shi H, et al. Efficacy and safety of probiotics and synbiotics for functional constipation in children: a systematic review and meta-analysis of randomized clinical trials[J]. Clin Nutr, 2023, 42(10): 1817-1826.
[34]	董梅. 儿童功能性便秘的生物反馈和心理行为治疗[J]. 临床儿科杂志, 2012, 30(10): 905-907.
	Dong M. Biofeedback and psychological behavioral therapy for functional constipation in children[J]. Linchuang Erke Zazhi, 2012, 30(10): 905-907.
[35]	Ansari Chaharsoghi N, Davoodi M, Reihani H, et al. A comparison of the effect of kegel exercises and conventional therapy versus conventional therapy alone in the treatment of functional constipation in children: a randomized clinical trial[J]. Iran J Med Sci, 2024, 49(5): 286-293.
[36]	Gordon M, MacDonald JK, Parker CE, et al. Osmotic and stimulant laxatives for the management of childhood constipation[J]. Cochrane Database Syst Rev, 2016, 2016(8): CD009118.
[37]	Roy D, Akriche F, Amlani B, et al. Utilisation and safety of polyethylene glycol 3350 with electrolytes in children under 2 years: a retrospective cohort[J]. J Pediatr Gastroenterol Nutr, 2021, 72(5): 683-689.
[38]	Worona-Dibner L, Vázquez-Frias R, Valdez-Chávez L, et al. Efficacy, safety, and acceptability of polyethylene glycol 3350 without electrolytes vs magnesium hydroxide in functional constipation in children from six months to eighteen years of age: a controlled clinical trial[J]. Rev Gastroenterol Mex (Engl Ed), 2023, 88(2): 107-117.
[39]	Jou DH, Kim SI, Choi IH, et al. Fatal hypermagnesemia in patients taking magnesium hydroxide[J]. Electrolyte Blood Press, 2023, 21(2): 66-71.
[40]	Bonilla S, Nurko S, Rodriguez L. Long-term use of Bisacodyl in pediatric functional constipation refractory to conventional therapy[J]. J Pediatr Gastroenterol Nutr, 2020, 71(3): 288-291.
[41]	Chang L, Chey WD, Imdad A, et al. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: pharmacological management of chronic idiopathic constipation[J]. Gastroenterology, 2023, 164(7): 1086-1106.
[42]	Chen JJ, Kitzia Colliard RN, Nurko S, et al. Melanosis coli is not associated with colonic dysmotility nor severity of pediatric functional constipation[J]. Dig Dis Sci, 2022, 67(8): 3922-3928.
[43]	Elkaragy ES, Shamseya MM, Metwally RH, et al. Efficacy of lubiprostone for functional constipation treatment in adolescents and children: randomized controlled trial[J]. J Pediatr Gastroenterol Nutr, 2024, 78(4): 800-809.
[44]	Benninga MA, Hussain SZ, Sood MR, et al. Lubiprostone for pediatric functional constipation: randomized, controlled, double-blind study with long-term extension[J]. Clin Gastroenterol Hepatol, 2022, 20(3): 602-610.
[45]	Di Lorenzo C, Khlevner J, Rodriguez-Araujo G, et al. Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial[J]. Lancet Gastroenterol Hepatol, 2024, 9(3): 238-250.
[46]	Kilgore A, Khlevner J. Functional constipation: pathophysiology, evaluation, and management[J]. Aliment Pharmacol Ther, 2024, 60 Suppl 1: S20-S29.
[47]	Winter HS, Di Lorenzo C, Benninga MA, et al. Oral prucalopride in children with functional constipation[J]. J Pediatr Gastroenterol Nutr, 2013, 57(2): 197-203.
[48]	Mugie SM, Korczowski B, Bodi P, et al. Prucalopride is no more effective than placebo for children with functional constipation[J]. Gastroenterology, 2014, 147(6): 1285-1295.
[49]	Velez A, Kaul A, El-Chammas KI, et al. Safety and effectiveness of prucalopride in children with functional constipation with and without upper symptoms[J]. Paediatr Drugs, 2024, 26(2): 187-195.
[50]	Cuffari C, Spalding W, Achenbach H, et al. Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation[J]. Contemp Clin Trials Commun, 2023, 33: 101144.
[51]	van der Wilt AA, Groenewoud HHM, Benninga MA, et al. Costeffectiveness of sacral neuromodulation for chronic refractory constipation in children and adolescents: a Markov model analysis[J]. Colorectal Dis, 2017, 19(11): 1013-1023.